Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07238166

Benign Versus Malignant Causes of Intussuception in Adults

The aim of this study is to evaluate adult intussecption :

* Prevalence of benign vs malignant causes. * Distribution by anatomical type. * Clinical presentation patterns. * Diagnostic accuracy of imaging. * Surgical approach and outcomes. * Length of hospital stay, complications, recurrence

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of general surgury Assiut uneversity hospital

Asyut, Egypt

Location contact

Andrew gamal fikry, MBBCh, MSc (general surgury)

CONTACT

[email protected]

+201224173419

About this study

Intussusception is a condition characterized by the invagination of one segment of the intestine into another, leading to obstruction and potentially ischemia (1). While intussusception is relatively common in the pediatric population, it is considered a rare clinical entity in adults, accounting for only 1-5% of all cases and approximately 1% of intestinal obstructions in the adult population. The etiology, clinical presentation, and management of adult intussusception differ significantly from pediatric cases, necessitating a distinct clinical approach (2).

In contrast to children, where most cases are idiopathic, adult intussusception is commonly associated with an underlying pathological lead point. In approximately 70-90% of adult cases, a structural lesion can be identified as the cause of the intussusception (3). These lesions may be benign or malignant in nature and understanding the incidence of each is important for appropriate diagnosis and treatment planning (4).

In general, intussusceptions involving the small intestine are more likely to be caused by benign lesions such as lipomas, polyps, or Meckel's diverticulum, whereas those involving the colon have a higher likelihood of being associated with malignancy, especially primary adenocarcinoma (5).

Adult intussusception poses a diagnostic challenge due to its nonspecific and often chronic symptoms, which may include intermittent abdominal pain, nausea, vomiting, gastrointestinal bleeding, or signs of partial bowel obstruction (6).

The advent of advanced imaging techniques, particularly abdominal computed tomography (CT), has improved the preoperative diagnosis of this condition (7). However, surgical exploration remains the definitive diagnostic and therapeutic modality, especially given the high probability of underlying malignancy (8).

Despite advancements in diagnostic imaging and surgical techniques, there remains a lack of general agreement regarding the optimal management of adult intussusception, particularly concerning the necessity and extent of bowel resection when a benign cause is suspected (9). Moreover, data on the relative incidence of benign versus malignant causes vary widely across regions, institutions, and populations.

This study aims to evaluate adult intussecption, prevalence of benign versus malignant causes in AUH.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

a. Inclusion criteria:

  • Age ≥ 19 years.
  • Confirmed diagnosis of intussusception by: Imaging (CT , ultrasound , or barium studies) Intraoperative findings,
  • Patients managed surgically with documented follow-up and final diagnosis. b. Exclusion criteria:
  • Patients with incomplete records or lost to follow-up
  • Intussusception diagnosed radiologically but resolved spontaneously without confirmatory intervention or follow-up

Treatment and study plan

surgical resection and histopathological examination

Procedure

Adult patient diagnosed with intussusception will undergo surgical resection of affected bowel segment under general anathesia . the resected specimens will be sent for histopathological evalution to determine the underlying cause , whether benign (e.g lipoma , polyp )or malignant (e.g adenocarcinama , lymphoma ). operative finding , postoperative outcome , and pathology results will be recorded and analyzed

Primary outcomes

  1. prevalence of benign versus malignant causes

    Time frame: 2 weeks after surgical resection

    Histopathological examination of resected bowel specimens will determine whether the cause of intussusception is benign (e.g., lipoma, polyp) or malignant (e.g., adenocarcinoma, lymphoma). The frequency and percentage of each category will be calculated

Secondary outcomes

  1. Correlation between preoperative imaging findings and histopathological results Description

    Time frame: At the time of diagnosis (preoperative period )

    Evaluate the diagnostic accuracy of preoperative imaging (CT scan findings such as target sign, mass lesion) in predicting benign or malignant pathology

Other outcomes

  1. Operative findings

    Time frame: During intraoperative period

    To record intraoperative findings including location of intussusception (small bowel, ileocecal, colocolic), presence of lead point, bowel viability, and type of surgical procedure

Study contacts

Contact information is provided by the study sponsor or research team.

Andrew gamal fikry, MBBCH, MSc ( general surgury )

CONTACT

[email protected]

+201224173419

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Benign Versus Malignant Causes of Intussuception in Adults : A Prospective Study in Assiut University Hospital

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Nov 20, 2025
Registry last updated
Nov 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.